{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:45:20Z","timestamp":1774449920083,"version":"3.50.1"},"reference-count":34,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/ol.2015.3950","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T10:45:01Z","timestamp":1448016301000},"page":"693-698","source":"Crossref","is-referenced-by-count":14,"title":["Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma"],"prefix":"10.3892","volume":"11","author":[{"given":"YINGYING","family":"CUI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENCHANG","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHANGSEN","family":"LENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAORUI","family":"FU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LING","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUDONG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FEIFEI","family":"NAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHAOMING","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAQIN","family":"YAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINGZHI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENCAI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANNAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANDAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAOZHEN","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"key":"key20180108095525_b1-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2407-10-358","article-title":"Primary gastric non-Hodgkin's lymphoma in Chinese patients: Clinical characteristics and prognostic factors","volume":"10","author":"Huang","year":"2010","journal-title":"BMC Cancer"},{"key":"key20180108095525_b2-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/annonc\/mdn525","article-title":"Primary extranodal lymphomas of stomach: Clinical presentation, diagnostic pitfalls and management","volume":"19","author":"Psyrri","year":"2008","journal-title":"Ann Oncol"},{"key":"key20180108095525_b3-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/cncr.11415","article-title":"Primary gastrointestinal lymphoma in Japan: A clinicopathologic analysis of 455 patients with special reference to its time trends","volume":"97","author":"Nakamura","year":"2003","journal-title":"Cancer"},{"key":"key20180108095525_b4-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10428199309059573","article-title":"Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registry","volume":"12","author":"D'Amore","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"key20180108095525_b5-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","article-title":"Treatment results in localized primary gastric lymphoma: Data of patients registered within the German multicenter study (GIT NHL 02\/96)","volume":"23","author":"Koch","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108095525_b6-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett"},{"key":"key20180108095525_b7-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"12818","DOI":"10.3748\/wjg.v20.i36.12818","article-title":"Hematologic manifestations of Helicobacter pylori infection","volume":"20","author":"Campuzano-Maya","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180108095525_b8-ol-0-0-3950","first-page":"737","article-title":"Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer","volume":"51","author":"Konturek","year":"2000","journal-title":"J Physiol Pharmacol"},{"key":"key20180108095525_b9-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.prp.2008.01.002","article-title":"Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma","volume":"204","author":"Yamac","year":"2008","journal-title":"Pathol Res Pract"},{"key":"key20180108095525_b10-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"701\u2013721","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"key20180108095525_b11-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2013.09.017","article-title":"Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-\u03baB induced matrix metalloproteinases 2 and 9 expression","volume":"65","author":"Zeng","year":"2014","journal-title":"Cytokine"},{"key":"key20180108095525_b12-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"e88270","DOI":"10.1371\/journal.pone.0088270","article-title":"Elevated interleukin-32 expression is associated with Helicobacter pylori-related gastritis","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"key":"key20180108095525_b13-ol-0-0-3950","first-page":"73","article-title":"Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis","volume":"31","author":"Gui","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"key20180108095525_b14-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2567.2010.03377.x","article-title":"Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene","volume":"132","author":"Lee","year":"2011","journal-title":"Immunology"},{"key":"key20180108095525_b15-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"e1985","DOI":"10.1371\/journal.pone.0001985","article-title":"Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection","volume":"3","author":"Li","year":"2008","journal-title":"PLoS One"},{"key":"key20180108095525_b16-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/1097-0142(197808)42:2<693::AID-CNCR2820420241>3.0.CO;2-J","article-title":"Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease","volume":"42","author":"Lewin","year":"1978","journal-title":"Cancer"},{"key":"key20180108095525_b17-ol-0-0-3950","first-page":"1401","article-title":"Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues","volume":"50","author":"Tomonaga","year":"2009","journal-title":"Rinsho Ketsueki"},{"key":"key20180108095525_b18-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner","year":"1994","journal-title":"Ann Oncol"},{"key":"key20180108095525_b19-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3892\/ol.2014.2371","article-title":"Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis","volume":"8","author":"Li","year":"2014","journal-title":"Oncol Lett"},{"key":"key20180108095525_b20-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(95)90113-2","article-title":"MALT Lymphoma Study Group: Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection","volume":"345","author":"Bayerd\u00f6rffer","year":"1995","journal-title":"Lancet"},{"key":"key20180108095525_b21-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"W\u00fcndisch","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108095525_b22-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/blood-2012-01-404194","article-title":"Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas","volume":"119","author":"Kuo","year":"2012","journal-title":"Blood"},{"key":"key20180108095525_b23-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/10428190310001654032","article-title":"Cyclooxygenase-2 (Cox-2) expression in lymphomas","volume":"45","author":"Hazar","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"key20180108095525_b24-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.leukres.2009.02.015","article-title":"Prognostic (corrected) significance of angiogenic\/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature","volume":"33","author":"Paydas","year":"2009","journal-title":"Leuk Res"},{"key":"key20180108095525_b25-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0145-2126(03)00183-8","article-title":"Increased cyclooxygenase-2 (COX-2): A potential role in the pathogenesis of lymphoma","volume":"28","author":"Wun","year":"2004","journal-title":"Leuk Res"},{"key":"key20180108095525_b26-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/jid.2013.488","article-title":"The role of IL-32 in cutaneous T-cell lymphoma","volume":"134","author":"Suga","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key20180108095525_b27-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/gut.37.4.471","article-title":"Lymphocytic gastritis and Helicobacter pylori infection in gastric lymphoma","volume":"37","author":"Miettinen","year":"1995","journal-title":"Gut"},{"key":"key20180108095525_b28-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/00365520802530853","article-title":"Effect of Helicobacter pylori infection on IL-8, IL-1\u03b2 and COX-2 expression in patients with chronic gastritis and gastric cancer","volume":"44","author":"Bartchewsky","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"key20180108095525_b29-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/cncr.11437","article-title":"Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma","volume":"97","author":"Denkert","year":"2003","journal-title":"Cancer"},{"key":"key20180108095525_b30-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v10.i13.1862","article-title":"Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma","volume":"10","author":"Li","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20180108095525_b31-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10014-012-0127-8","article-title":"Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: Immunohistochemical analysis of 76 cases of low and high-grade meningioma","volume":"31","author":"Kato","year":"2014","journal-title":"Brain Tumor Pathol"},{"key":"key20180108095525_b32-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s12032-011-0098-3","article-title":"Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer","volume":"29","author":"Al-Moundhri","year":"2012","journal-title":"Med Oncol"},{"key":"key20180108095525_b33-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12032-013-0472-4","article-title":"IL-32 expression is an independent prognostic marker for gastric cancer","volume":"30","author":"Ishigami","year":"2013","journal-title":"Med Oncol"},{"key":"key20180108095525_b34-ol-0-0-3950","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/PAS.0b013e31828b6ad3","article-title":"Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma","volume":"37","author":"Koh","year":"2013","journal-title":"Am J Surg Pathol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3950\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:49:28Z","timestamp":1567363768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,20]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/ol.2015.3950"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3950","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}